Subject: Session clin.trial. A Single-Centre, Open-Label, Five-Period Crossover Trial In Volunteers Investigating the Relative Bioavailability ХIf Х was not sufficiently detectable in the blood for assessment of bioavailablity and there were no concerns regarding the safety of the doses of Х administered in Sessions 1, 2 and 3, subjects could progress to Session 6. Subjects studied in Session 1 were not recruited to the subsequent sessions. Blood samples for evaluation of plasma drug concentrations were taken at regular intervals up to 24 h after dosing in Sessions 1, 2, 3 and 6 (dosing with Х) and up to 6 h after dosing in Sessions 4 and 5 (dosing with У). Подскажите, пожалуйста |
1. Как хотите (часть, стадия, этап и т.д.), важно чтобы не пересекалось далее с названиями других классификаторов. 2. Не включались в последующие. |
Понятно, думала может есть спец название для Session.. |
You need to be logged in to post in the forum |